<DOC>
	<DOCNO>NCT02136927</DOCNO>
	<brief_summary>Pharmacokinetic , bioequivalence study</brief_summary>
	<brief_title>Bioavailability Study SPARC1210 Reference1210 Subjects With Metastatic Breast Cancer</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>The subject give write , informed consent available entire study . Histologically cytologically confirm diagnosis breast cancer ; Locally recurrent metastatic breast cancer taxanebased therapy rational treatment option ; Age 18 year Known hypersensitivity study drug excipients ( Cholesteryl sulfate , Caprylic acid , Polyvinylpyrrolidone , Ethanol Polyethylene glycol ) ; Presence clinically evident active CNS metastasis , include leptomeningial involvement , require steroid radiation therapy ; Preexisting clinically significant peripheral neuropathy ( Grade 2 high accord CTCAE , Version 4.0 ) ; Any severe concurrent disease judgment investigator would make subject inappropriate entry study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>